VOR Stock Analysis: Buy, Sell, or Hold?
VOR - Vor Biopharma Inc. Common Stock
$18.03
-1.11 (-5.80%)
▼
5d:
-10.3%
30d:
+38.69%
90d:
+16.55%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When VOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VOR is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: VOR is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VOR is currently trading at $18.03, which is considered slightly high relative to its 30-day fair value range of $13.63 to $18.83.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $15.85, while resistance sits at $22.22. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: VOR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $37.88 (+110.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $15.85, while resistance sits at $22.22. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: VOR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $37.88 (+110.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$13.63 -
$18.83
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
- BULLISH: Trading 110.1% below Wall St target ($37.88)
- WARNING: Recommendation downgraded due to -10.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$13.63 -
$18.83
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$15.85
Resistance Level
$22.22
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.82
Wall Street Target
$37.88
(+110.1%)
Share & Embed Analysis
Last updated: July 14, 2026 7:14 AM ET
Data refreshes hourly during market hours. Next update: 8:14 AM
Data refreshes hourly during market hours. Next update: 8:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VOR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Ra Capital Management, L…
SELL
165150 shares
2026-04-22
Ra Capital Management, L…
SELL
171963 shares
2026-04-20
Ra Capital Management, L…
SELL
458411 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 45 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
